CD19 CAR T cell product and disease attributes predict leukemia remission durability.
Saved in:
| Title: | CD19 CAR T cell product and disease attributes predict leukemia remission durability. |
|---|---|
| Authors: | Finney OC, Brakke HM, Rawlings-Rhea S, Hicks R, Doolittle D, Lopez M, Futrell RB, Orentas RJ, Li D, Gardner RA, Jensen MC |
| Source: | The Journal of clinical investigation [J Clin Invest] 2019 Mar 12; Vol. 129 (5), pp. 2123-2132. Date of Electronic Publication: 2019 Mar 12 (Print Publication: 2019). |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
